RBC Capital Maintains Outperform on Zynex, Lowers Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh maintains an Outperform rating on Zynex (NASDAQ:ZYXI) but lowers the price target from $15 to $12.
July 26, 2024 | 2:46 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
RBC Capital analyst Shagun Singh maintains an Outperform rating on Zynex but lowers the price target from $15 to $12.
The Outperform rating suggests continued confidence in Zynex's performance, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100